Anatomical, physiological, and functional diversity of adipose tissue

RK Zwick, CF Guerrero-Juarez, V Horsley, MV Plikus - Cell metabolism, 2018 - cell.com
Adipose tissue depots can exist in close association with other organs, where they assume
diverse, often non-traditional functions. In stem cell-rich skin, bone marrow, and mammary …

New insights into the pathogenesis and nonsurgical management of Graves orbitopathy

PN Taylor, L Zhang, RWJ Lee, I Muller… - Nature Reviews …, 2020 - nature.com
Graves orbitopathy, also known as thyroid eye disease or thyroid-associated orbitopathy, is
visually disabling, cosmetically disfiguring and has a substantial negative impact on a …

Graves' ophthalmopathy

RS Bahn - New England Journal of Medicine, 2010 - Mass Medical Soc
This article reviews the mechanisms that lead to the development of Graves'
ophthalmopathy. A central feature in its development is autoimmunity that involves not only T …

Teprotumumab for the treatment of Thyroid eye disease

S Ugradar, E Malkhasyan, RS Douglas - Endocrine Reviews, 2024 - academic.oup.com
Thyroid eye disease (TED) is the most common extra thyroidal manifestation of Graves'
disease (GD). It may also present in those who are hypothyroid or euthyroid. The …

Pathogenesis of thyroid eye disease: review and update on molecular mechanisms

JJ Khong, AA McNab, PR Ebeling, JE Craig… - British Journal of …, 2016 - bjo.bmj.com
Orbital changes in thyroid orbitopathy (TO) result from de novo adipogenesis, hyaluronan
synthesis, interstitial oedema and enlargement of extraocular muscles. Cellular immunity …

Current insights into the pathogenesis of Graves' ophthalmopathy

RS Bahn - Hormone and Metabolic Research, 2015 - thieme-connect.com
Environmental, genetic, and immune factors are at play in the development of the variable
clinical manifestations of Graves' ophthalmopathy (GO). Among the environmental …

Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy

WA Dik, S Virakul, L van Steensel - Experimental Eye Research, 2016 - Elsevier
Graves' ophthalmopathy (GO) is an extra-thyroidal complication of Graves' disease (GD;
Graves' hyperthyroidism) characterized by orbital tissue inflammation, expansion …

TSH/IGF-1 receptor cross talk in Graves' ophthalmopathy pathogenesis

CC Krieger, RF Place, C Bevilacqua… - The Journal of …, 2016 - academic.oup.com
Abstract Context: The TSH receptor (TSHR) is considered the main target of stimulatory
autoantibodies in the pathogenesis of Graves' ophthalmopathy (GO); however, it has been …

Immunological aspects of Graves' ophthalmopathy

D Łacheta, P Miśkiewicz, A Głuszko… - BioMed research …, 2019 - Wiley Online Library
The body's autoimmune process is involved in the development of Graves' disease (GD),
which is manifested by an overactive thyroid gland. In some patients, autoreactive …

Hyaluronan synthase 1: a mysterious enzyme with unexpected functions

H Siiskonen, S Oikari, S Pasonen-Seppänen… - Frontiers in …, 2015 - frontiersin.org
Hyaluronan synthase 1 (HAS1) is one of three isoenzymes responsible for cellular
hyaluronan synthesis. Interest in HAS1 has been limited because its role in hyaluronan …